It’s not uncommon for shareholders to disagree with the boards that are supposed to represent their interests. Directors are privy to a lot of inside information that isn’t available to the public. They make decisions that can’t be divulged, sometimes forever. They balance risks against potential gains in initiatives that don’t always produce the desired
Read More
It’s not a question of AstraZeneca or Pfizer for digital health company ResApp Health (ASX: RAP) who have today entered into a binding scheme implementation deed to be acquired by pharmaceutical giant, Pfizer. Yes, one of the world’s biggest pharma companies has been perusing the ASX for a small homegrown biotech to snap up, we’re
Read More
Confirming the efficacy and broader potential of their smartphone-based diagnostic app, ResApp Health Limited (ASX: RAP) clinical data referenced in a top academic publication has validated their app’s accuracy for respiratory diagnostics. Data from their Breathe Easy adult clinical study has been published in a peer-reviewed Nature partner journal, npj Digital Medicine. The study looked
Read More
Amid the growing concerns around coughing in public for the obvious reason, medtech company ResApp Health (ASX: RAP) has secured regulatory approval in Europe for their wearable device that analyses a person’s cough and the medical implications. The device, which is yet to be named, can be easily clipped on to a person’s shirt where
Read More
Australian medtech company ResApp (ASX: RAP) is set to make diagnosing sleep apnoea significantly easier for individuals with the launch of the SleepCheck smartphone app which has been clinically tested. Obstructive sleep apnoea (OSA) is one of the most common sleep breathing disorders which affects around 30%of men and 20%of women. However, studies show that
Read More